Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
OrigiMed and Takeda Announced Partnership to Accelerate R&D and Commercialization of Innovative Medicines 2020-11-11 21:26
I-Mab Announces Preclinical Data on Differentiated Anti-C5aR Antibody TJ210/MOR210 at SITC 2020 2020-11-11 21:00
Asieris Announces First Patient Administration in the Global Phase III Clinical Trial for APL-1702 2020-11-11 17:08
Monograph Published by World Scientific Publishing Proves Asclepius Meditec's Hydrogen Oxygen Generator with Nebulizer Effective in Treating COVID-19 2020-11-11 16:07
All Blacks Name Hyperice Official Recovery Technology Supplier 2020-11-11 04:00
Bioheng Announced Oral Presentation of Its Preliminary Results of CRISPR-Engineered Allogeneic CAR-T for r/r B-ALL Treatment at 2020 ASH Meeting 2020-11-10 22:30
S. Korea's KT Corp. to Expand Digital Health Business with Sibel 2020-11-10 22:00
Volition Veterinary Presents Expert Report Ahead of First Product Launch 2020-11-10 21:00
I-Mab Reports Phase 1 Clinical Trial Data of Highly Differentiated Anti-CD47 Monoclonal Antibody Lemzoparlimab at the 2020 SITC Annual Meeting 2020-11-09 21:12
VolitionRx Limited Schedules Third Quarter 2020 Earnings Conference Call and Business Update 2020-11-09 21:00
GenScript Receives FDA Emergency Use Authorization for World's First SARS-CoV-2 Neutralizing Antibody Detection Kit 2020-11-09 20:30
TaiGen Partners with GPCR to develop Burixafor & Taigexyn(R) 2020-11-09 18:22
Termination of Bridge Biotherapeutics's Collaboration and License Agreement with Boehringer Ingelheim 2020-11-09 18:07
Inmagene Biopharmaceuticals closed $21 million Series B financing, making the total raised to date over $40 million 2020-11-09 08:00
2020 Tencent Medical Enlightenment Summit: Popularizing Science to Overcome Challenges 2020-11-08 19:00
CARE GA Receives Study May Proceed Letter from US FDA to Initiate Phase II Clinical Trial of Senhwa's Silmitasertib in COVID-19 Patients 2020-11-06 22:00
Daewoong Pharmaceutical Announces Publication of Novel P-CAB Fexuprazan Phase 1 Bridging Study 2020-11-06 22:00
New Drug for Gastrointestinal Stromal Tumours (GIST) to be Launched in Australia, New Zealand and South East Asia Following Distribution Agreement 2020-11-06 05:30
PolyActiva successfully completes initial clinical trial with Latanoprost FA SR Ocular Implant delivering glaucoma treatment to patients over a six-month period 2020-11-05 21:00
Porton Biologics Launched Gene and Cell Therapy CDMO Platform to Rank Among the Top of Pharma Solutions Platforms 2020-11-05 15:35
1 249 250 251 252 253 811